Playing Game to Learn About Children's Vaccine Project
NCT05984849 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2026-05-20
Summary
This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
Conditions
- HPV
- Vaccine-Preventable Diseases
Interventions
- BEHAVIORAL
-
vaccination game
A health game to promote HPV vaccination among youth
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
ANGELA C CHEN, PhD · Michigan State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 11 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-27
- Primary Completion
- 2027-06-30
- Completion
- 2027-08-31
Countries
- United States
Study Locations
More Related Trials
-
Video to Promote HPV Vaccination
NCT02196454 ·Status: COMPLETED ·Phase: NA
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination
NCT02537756 ·Status: COMPLETED ·Phase: NA
-
PREVENT HPV -Related Cancers Trial
NCT07217145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents
NCT04438291 ·Status: COMPLETED ·Phase: NA
-
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
NCT04474821 ·Status: COMPLETED ·Phase: PHASE4
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
NCT02535845 ·Status: TERMINATED ·Phase: NA
-
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
NCT03429413 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination
NCT02145156 ·Status: COMPLETED ·Phase: NA
-
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
NCT03759236 ·Status: COMPLETED ·Phase: NA
-
Communication Strategies to Increase HPV Vaccination Intention
NCT06784960 ·Status: COMPLETED ·Phase: NA
-
Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise
NCT03604393 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women
NCT06220747 ·Status: RECRUITING
-
HPV Ends Here: Increasing Uptake of the HPV Vaccine
NCT06831929 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women
NCT00689741 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi
NCT05658198 ·Status: ENROLLING_BY_INVITATION
-
Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students
NCT01568515 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
NCT06229353 ·Status: TERMINATED
-
Usability of HPV Vaccine Reminders
NCT03987490 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students
NCT06631794 ·Status: NOT_YET_RECRUITING
-
Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old
NCT06435338 ·Status: COMPLETED ·Phase: NA
-
Provider Recommendation and HPV Vaccination
NCT05365048 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
NCT00294047 ·Status: COMPLETED ·Phase: PHASE3
-
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
NCT03609320 ·Status: UNKNOWN ·Phase: NA
-
Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)
NCT00365378 ·Status: COMPLETED ·Phase: PHASE2